Pelican v. 3M Company

CourtDistrict Court, D. Minnesota
DecidedSeptember 12, 2025
Docket0:23-cv-01818
StatusUnknown

This text of Pelican v. 3M Company (Pelican v. 3M Company) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pelican v. 3M Company, (mnd 2025).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

In re: BAIR HUGGER FORCED AIR MDL No. 15-2666 (JNE/DTS) WARMING DEVICES PRODUCTS ORDER LIABILITY LITIGATION

This Document Relates to: Case No. 23-cv-1818 (Gary G. Pelican v. 3M Company and Arizant Healthcare, Inc.)

In May 2016, Gary Pelican, a resident and citizen of Louisiana, “underwent surgery during which the Bair Hugger Forced Air Warming system (hereinafter ‘Bair Hugger’) was used during the course and scope of his surgery at the Lake Charles Memorial Hospital, in Lake Charles, Louisiana.” (Compl. ¶¶ 2, 7)1 He alleged that “[c]ontaminants introduced into [his] open surgical wound as a direct and proximate result of use of the Bair Hugger during the subject surgery resulted in [him] developing a periprosthetic joint infection.” (Compl. ¶ 8) “As a result of [his] infection caused by the Bair Hugger, [Pelican] has undergone numerous procedures following a postoperative infection, requiring intervention, management, and surgeries.” (Compl. ¶ 9) In June 2023, Pelican brought this action against 3M Company and Arizant Healthcare, Inc. (collectively, “Defendants”). He asserted several claims: negligence; strict liability based on failure to warn; strict liability based on defective design and manufacture; breach of express warranty; breach of implied warranty of merchantability; violation of the Minnesota Prevention of Consumer Fraud Act; violation of the Minnesota Deceptive Trade Practices Act; violation of the Minnesota Unlawful Trade Practices Act;

1 Pelican’s Complaint states that the surgery took place in December 2014. His fact sheet and medical records indicate that the surgery took place in May 2016. violation of the Minnesota False Advertising Act; consumer fraud and/or unfair and deceptive trade practices under Louisiana law; negligent misrepresentation; fraudulent

misrepresentation; fraudulent concealment; unjust enrichment; punitive damages; common law fraud; constructive fraud; gross negligence; and negligent infliction of emotional distress. The case is before the Court on Defendants’ Motion for Summary Judgment and Motion to Exclude the Opinions and Testimony of Plaintiff’s Expert Dr. Yoav Golan. For the reasons set forth below, the Court grants Defendants’ Motion for Summary Judgment and denies their motion to exclude as moot.

I. Summary Judgment Summary judgment is proper “if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). To support an assertion that a fact cannot be or is genuinely disputed, a party must cite “to particular parts of materials in the record” or show “that the materials

cited do not establish the absence or presence of a genuine dispute, or that an adverse party cannot produce admissible evidence to support the fact.” Fed. R. Civ. P. 56(c)(1). “The court need consider only the cited materials, but it may consider other materials in the record.” Fed. R. Civ. P. 56(c)(3). In determining whether summary judgment is appropriate, a court must view genuinely disputed facts in the light most favorable to the

nonmovant, Ricci v. DeStefano, 557 U.S. 557, 586 (2009), and draw all justifiable inferences from the evidence in the nonmovant’s favor, Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255 (1986). Defendants maintained that summary judgment in their favor is appropriate because (1) “all 19 of [Pelican’s] claims are time-barred under Louisiana’s one-year

prescriptive period”; (2) his “claims . . . fail because [he] lacks admissible evidence of specific causation”; (3) his “failure-to-warn claim fails because no reasonable jury could conclude that a warning was necessary”; (4) his “breach of warranty claim fails because [he] has no evidence of an actionable express warranty, let alone one that was relied upon and caused [him] injury”; (5) “the majority of [his] claims (16 of the 19 claims alleged) are not cognizable under Louisiana law”; and (6) several claims “fail . . . on the merits.”

Pelican responded that his claims under the Louisiana Product Liability Act (“LPLA”) and “demand for punitive damages are viable claims”; that “the remainder of his claims are abrogated or not allowed”; that his “claims were timely brought”; that he “proffered sufficient evidence of causation to create a genuine issue of material fact in favor of his claims”; that he “proffered sufficient evidence for a reasonable jury to find that

Defendant should have warned medical providers of the link between the [Bair Hugger] and [periprosthetic joint infections] before the [Bair Hugger] was used in [his] surgery”; and that his “claims for punitive damages are subject to Minnesota law, not Louisiana law, and Minnesota law provides for an award of punitive damages in a product liability claim.” Considering Pelican’s statement that his non-LPLA claims “are abrogated or not

allowed,” the Court dismisses them and turns to whether his remaining claims are time- barred. Cf. Travers v. Chubb Eur. Grp. SE, 714 F. Supp. 3d 812, 819 (E.D. La. 2024) (“[P]unitive damages cannot be pleaded as an independent cause of action but rather must be requested in conjunction with a cognizable cause of action.” (citation omitted)); Forster v. R.J. Reynolds Tobacco Co., 437 N.W.2d 655, 662–63 (Minn. 1989) (“A claim for punitive damages in this state is not an independent tort.”).

“Delictual actions are subject to a liberative prescription of one year. This prescription commences to run from the day injury or damage is sustained.” La. Civ. Code art. 3492 (repealed 2024); see Allied World Nat’l Assurance Co. v. Nisus Corp., 134 F.4th 821, 826–827 (5th Cir. 2025).2 “Damage is considered to have been sustained, within the meaning of [Article 3492], only when it has manifested itself with sufficient certainty to support accrual of a cause of action.” In re Taxotere (Docetaxel) Prods.

Liab. Litig., 995 F.3d 384, 389 (5th Cir. 2021) (alteration in original) (citation omitted). “But ‘[u]nder Louisiana law, there is a firmly rooted equitable-tolling doctrine known as contra non valentem agere non currit praescriptio, which means “[n]o prescription runs against a person unable to bring an action.”’” Allied World, 134 F.4th at 827 (alteration in original) (citation omitted). “The doctrine tolls prescription under any of four

‘exceptional circumstances,’ one of which is ‘where the cause of action is not known or reasonably knowable by the plaintiff,’ termed the ‘discovery rule.’” Bruno v. Biomet, Inc., 74 F.4th 620, 623 (5th Cir. 2023) (citation omitted). “Under the discovery rule, ‘[a]ctual knowledge is not required’ for prescription to start running; ‘constructive notice suffices.’ ‘Constructive knowledge or notice sufficient

to commence the running of prescription requires more than a mere apprehension

2 “In Louisiana, ‘limitations periods are often called “prescriptions” or “prescriptive periods.”’ Under LA. CIV. CODE art.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Ricci v. DeStefano
557 U.S. 557 (Supreme Court, 2009)
B & B Hardware, Inc. v. Fastenal Co.
688 F.3d 917 (Eighth Circuit, 2012)
Forster v. R.J. Reynolds Tobacco Co.
437 N.W.2d 655 (Supreme Court of Minnesota, 1989)
Bruno v. Biomet
74 F.4th 620 (Fifth Circuit, 2023)
Allied World National v. Nisus
134 F.4th 821 (Fifth Circuit, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
Pelican v. 3M Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pelican-v-3m-company-mnd-2025.